Pfizer Inc. held its 2026 Annual Meeting of Shareholders on April 23, where all Board nominees were elected and the auditor ratification and stock plan amendment were approved.
Key takeaways
All six Board nominees (Ronald E. Blaylock, Mortimer J. Buckley, Joseph J. Echevarria, Dan R. Littman, James C. Smith, Cyrus Taraporevala) elected with majority votes for.
KPMG LLP ratified as independent auditor for 2026 fiscal year with 4.16B votes for vs. 322M against.
Pfizer Inc. 2019 Stock Plan, as amended April 2026, approved with 3.23B votes for.
Advisory approval of 2026 Named Executive Officer compensation passed with 3.10B votes for.
Shareholder proposal for Independent Chair Policy rejected with 1.02B votes for vs. 2.51B against.
Broker non-votes consistent at 941,392,137 across proposals.